4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Xenon Pharmaceuticals Inc. (XENE) operates in the Biotechnology industry and is headquartered in Burnaby, Canada with about 358 employees. Its market capitalization is roughly $7 billion. In the fiscal year ended 2025-12-31, XENE reported $8M in revenue and ($346M) in net income.
Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $8M | $0M | $0M | $9M | — |
| Operating Income (EBIT) | ($373M) | ($279M) | ($214M) | ($129M) | — |
| Net Income | ($346M) | ($234M) | ($182M) | ($125M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $8M |
| Operating Income (EBIT) | ($112M) | ($110M) | ($96M) | ($94M) | ($73M) |
| Net Income | ($102M) | ($105M) | ($91M) | ($85M) | ($65M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $633M | $798M | $965M | $754M | — |
| Total Liabilities | $51M | $43M | $37M | $33M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive XENE viewer.
About TickerBase · Data methodology & sources